Literature DB >> 28993816

Psychological and psychobiological responses to immediate early intervention in the emergency department: Case report of one-session exposure therapy for the prevention of PTSD.

Loren M Post1, Vasiliki Michopoulos1,2, Jennifer S Stevens1, Renuka Reddy1, Jessica L Maples1,3, Jessica R Morgan1,4, Alex O Rothbaum1, Tanja Jovanovic1, Kerry J Ressler1,2,5, Barbara O Rothbaum1.   

Abstract

Research suggests that exposure therapy provided in the hours immediately following trauma exposure may prevent PTSD development. This case report presents data on an at-risk for PTSD participant involved in a motor-vehicle crash that caused her severe distress. She received one session of exposure therapy in the emergency department (ED) as part of an ongoing randomized controlled study examining the optimal dose of exposure therapy in the immediate aftermath of trauma. PTSD and depression measures were collected at pre-treatment assessment and one- and three-month follow-up. Potential PTSD biomarkers were also examined. Psychophysiological reactions were measured using skin conductance data measured on an iPad during the exposure therapy session and the follow-up assessments. A fear-potentiated startle paradigm and an functional magnetic resonance imaging (fMRI) behavioral inhibition task were used at follow-up. The participant demonstrated subjective and psychophysiological extinction from pre- to post-imaginal exposure. At follow-up, she did not meet DSM-IV criteria for PTSD or demonstrate hyperarousal to trauma reminders and showed robust fear extinction and the ability to inhibit responses in an fMRI behavioral inhibition task. In line with previous early intervention for the prevention of PTSD studies, this case report supports the need for ongoing empirical research investigating the possibility that one session of exposure therapy in the ED may attenuate risk for PTSD. Furthermore, the current findings demonstrate psychophysiological extinction serving as a prognostic indicator of treatment response for PTSD early intervention to be an exciting avenue to explore in future systematic research.

Entities:  

Keywords:  PTSD; early intervention; exposure therapy; memory consolidation; psychobiology

Year:  2017        PMID: 28993816      PMCID: PMC5630142          DOI: 10.1037/pri0000043

Source DB:  PubMed          Journal:  Pract Innov (Wash D C)        ISSN: 2377-889X


  21 in total

1.  Comparison of the PTSD Symptom Scale-Interview Version and the Clinician-Administered PTSD scale.

Authors:  E B Foa; D F Tolin
Journal:  J Trauma Stress       Date:  2000-04

2.  Different mechanisms of fear extinction dependent on length of time since fear acquisition.

Authors:  Karyn M Myers; Kerry J Ressler; Michael Davis
Journal:  Learn Mem       Date:  2006 Mar-Apr       Impact factor: 2.460

Review 3.  PTSD and gene variants: new pathways and new thinking.

Authors:  Kelly Skelton; Kerry J Ressler; Seth D Norrholm; Tanja Jovanovic; Bekh Bradley-Davino
Journal:  Neuropharmacology       Date:  2011-02-26       Impact factor: 5.250

4.  Early intervention following trauma may mitigate genetic risk for PTSD in civilians: a pilot prospective emergency department study.

Authors:  Barbara O Rothbaum; Megan C Kearns; Emily Reiser; Jennifer S Davis; Kimberly A Kerley; Alex O Rothbaum; Kristina B Mercer; Matthew Price; Debra Houry; Kerry J Ressler
Journal:  J Clin Psychiatry       Date:  2014-12       Impact factor: 4.384

Review 5.  Using experimental methodologies to assess posttraumatic stress.

Authors:  Tanja Jovanovic; Sheila Am Rauch; Alex O Rothbaum; Barbara O Rothbaum
Journal:  Curr Opin Psychol       Date:  2016-10-19

6.  A pilot study of an exposure-based intervention in the ED designed to prevent posttraumatic stress disorder.

Authors:  Barbara Olasov Rothbaum; Debra Houry; Mary Heekin; Amy Selvig Leiner; Jill Daugherty; L Shakiyla Smith; Maryrose Gerardi
Journal:  Am J Emerg Med       Date:  2008-03       Impact factor: 2.469

Review 7.  Biological studies of post-traumatic stress disorder.

Authors:  Roger K Pitman; Ann M Rasmusson; Karestan C Koenen; Lisa M Shin; Scott P Orr; Mark W Gilbertson; Mohammed R Milad; Israel Liberzon
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

8.  Emergency department predictors of posttraumatic stress reduction for trauma-exposed individuals with and without an early intervention.

Authors:  Matthew Price; Megan Kearns; Debra Houry; Barbara O Rothbaum
Journal:  J Consult Clin Psychol       Date:  2014-02-03

9.  Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder.

Authors:  Mohammed R Milad; Roger K Pitman; Cameron B Ellis; Andrea L Gold; Lisa M Shin; Natasha B Lasko; Mohamed A Zeidan; Kathryn Handwerger; Scott P Orr; Scott L Rauch
Journal:  Biol Psychiatry       Date:  2009-09-12       Impact factor: 13.382

10.  Versatility of fear-potentiated startle paradigms for assessing human conditioned fear extinction and return of fear.

Authors:  Seth D Norrholm; Kemp M Anderson; Ilana W Olin; Tanja Jovanovic; Cliffe Kwon; Victor T Warren; Alexander McCarthy; Lauren Bosshardt; Justin Sabree; Erica J Duncan; Barbara O Rothbaum; Bekh Bradley
Journal:  Front Behav Neurosci       Date:  2011-11-21       Impact factor: 3.558

View more
  3 in total

1.  A Multimethod Examination of the Effect of Insomnia Symptoms on Anxious Responding to a Social Stressor.

Authors:  Nicole A Short; Norman B Schmidt
Journal:  Behav Ther       Date:  2017-11-13

2.  Emotion dysregulation is associated with increased prospective risk for chronic PTSD development.

Authors:  Ioana Pencea; Adam P Munoz; Jessica L Maples-Keller; Devika Fiorillo; Katharina Schultebraucks; Isaac Galatzer-Levy; Barbara O Rothbaum; Kerry J Ressler; Jennifer S Stevens; Vasiliki Michopoulos; Abigail Powers
Journal:  J Psychiatr Res       Date:  2019-12-14       Impact factor: 4.791

3.  L-DOPA improves extinction memory retrieval after successful fear extinction.

Authors:  A M V Gerlicher; O Tüscher; R Kalisch
Journal:  Psychopharmacology (Berl)       Date:  2019-06-26       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.